
    
      The intervention group will be composed of individuals deceased in brain dead, after the
      conclusion of the brain dead protocol by the teams responsible for the Intensive care and
      will receive liraglutide. The control group will be composed of the same population of
      individuals who died in brain dead of the intervention group, but will receive a placebo.
    
  